Hori T, Yamamoto K, Aoi H, Koizumi Y, et al. Antiproteinuric Effect of SGLT2 Inhibitors in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab. Anticancer Res 2026;46:5141-5154.
PMID: 42674726